Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
AbbVie Inc.
C C C A A A A A A C A A A A A A A Y A A C C A A A C C
C07F C07D C07D A61K A61K A61K A61K A61P A61K C07D A61K A61K A61K A61K A61K A61K A61K Y02P A61P A61K C07D C07D A61P A61K A61K C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Seble H. Kathy Mary E. Ryan G. Mark A. Warren M. David A. Pamela L. Douglas K. Charles A. Sachin V. Jean C. Allan C. Charles W. Rolf William A. Dachun Kevin R. Todd W. Tammie K. Christopher E. Michael D. Yi Wenke John K. Lissa T. John T. David A. Clarence J. Daniel D.
Wagaw Sarris Bellizzi Keddy Matulenko Kati DeGoey Donner Hutchinson Flentge Patel Califano Krueger Hutchins Wagner Carroll Liu Woller Rockway Jinkerson Motter Tufano Gao Li Pratt Nelson Randolph Betebenner Maring Caspi